Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
In this episode of Top Biotechs at ASCO, Ruthie Davi, Senior Vice President at Medidata Solutions, shares how historical clinical trial data and AI-powered tools are reshaping cancer research and trial design.
- New analysis on platinum-resistant ovarian cancer post-PARP inhibitors
- Real-world applications of AI in oncology, including HER2-low detection and activity monitoring
- Introduction to Protocol Optimizer, a simulation tool for optimizing trial design before execution
- How Medidata’s data-sharing program leverages Rave to generate actionable insights across trials
- Use of historical data to build external control arms and improve efficiency in severe disease trials
From enhancing protocol efficiency to enabling patient-centric innovation, this conversation offers a glimpse into the future of oncology research powered by data and technology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 11:05
Jul 19, 2025, 10:29
Jul 19, 2025, 10:12
Jul 19, 2025, 09:55
Jul 19, 2025, 09:05
Jul 19, 2025, 08:54
Jul 19, 2025, 07:24
Jul 19, 2025, 07:23